See how Butterfly Network’s pivot toward chip licensing and software compares with peers riding similar trends by reviewing the hand picked 36 healthcare AI stocks now shaping medical imaging and diagnostics.
To own Butterfly Network, you need to believe the ultrasound platform can transition from selling mostly handheld devices to monetising its chips and software across many partners. The analyst consensus narrative on Simply Wall St already leans on embedded and software as key drivers. This new guidance that licensing could overtake hardware aligns with that story rather than changing it.
The near term swing factor still looks like execution on high margin embedded deals and keeping POCUS and international revenue from dragging. The biggest watchpoint stays the same. If core POCUS and overseas trends remain soft, chip progress may not translate into cleaner overall results.
The recent focus on licensing ties directly back to earlier commentary about embedded partnerships such as the five year Midjourney Medical agreement worth up to US$74m. That contract matters because it shows how Butterfly Network can use a single semiconductor platform across multiple partners instead of relying only on its own probes.
Seen through the catalyst lens, this embedded push sits alongside Home and Community Care pilots, FedRAMP access, and the P5.1 chip roadmap. The mix of these projects gives Butterfly Network several ways to support higher margin revenue, while dilution risk from the at the market program and ongoing losses remains a clear counterweight.
Butterfly Network's narrative projects US$228.4 million in revenue and US$29.4 million in earnings by 2029. This is based on analysts assuming 22.8% yearly revenue growth and would require an earnings improvement of about US$83.1 million from a current loss of US$53.7 million.
Uncover how Butterfly Network's fair value indicates an 84% potential upside to its current price, which could narrow quickly as sentiment catches up.
Not every analyst treats chip licensing as the key swing factor. The more optimistic group focuses on Butterfly Network’s Home and Community Care rollout, where they were already modeling revenue to reach about US$254.9 million and earnings of US$32.1 million by 2029. Those projections came before this news, so you may see their stories evolve from here.
Explore 4 other Butterfly Network fair value estimates, including one that suggests as much as 142% upside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
If the Butterfly Network story has sharpened how you think about risk, reward and business models, it can help to line it up against other opportunities that fit different goals. The Simply Wall St Screener lets you scan the market in a few clicks so you can compare Butterfly Network with companies that have very different profiles.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com